APA (7th ed.) Citation

H, Q., T, Q., N, Y., W, S., J, D., J, Q., . . . F, Y. (2026). Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: A multi-omics and clinical validation study. NPJ precision oncology, 10(1), . https://doi.org/10.1038/s41698-026-01298-0

Chicago Style (17th ed.) Citation

H, Qin, et al. "Cuproptosis-associated PDHA1 Promotes Sarcoma Progression and Immunotherapy Responsiveness via the E2F1-PD-L1 Axis: A Multi-omics and Clinical Validation Study." NPJ Precision Oncology 10, no. 1 (2026). https://doi.org/10.1038/s41698-026-01298-0.

MLA (9th ed.) Citation

H, Qin, et al. "Cuproptosis-associated PDHA1 Promotes Sarcoma Progression and Immunotherapy Responsiveness via the E2F1-PD-L1 Axis: A Multi-omics and Clinical Validation Study." NPJ Precision Oncology, vol. 10, no. 1, 2026, https://doi.org/10.1038/s41698-026-01298-0.